Synchron Systems Direct Ldl Chloesterol Reagent and Calibrator
System, Test, Low Density, Lipoprotein. 510(k) K014103, from Beckman Coulter, Inc. (Brea, CA). Product code MRR, class 1.
As of Nov 19, 2026, K014103 is an FDA 510(k) held by Beckman Coulter, Inc., substantially equivalent on Jan 28, 2002 after 46 days, with 1 recall tied to it in FDA's recall database.
- Review time: 46 days
- Recalls: 1
The SYNCHRON® Systems Direct LDL Cholesterol (LDLD) Reagent, when used in conjunction with SYNCHRON® Systems LDLD Calibrator, is intended for the quantitative determination of low density lipoprotein cholesterol in serum and plasma on Beckman Coulter's SYNCHRON Systems by colorimetry. LDL cholesterol is directly related to the risk of developing coronary heart disease.
- N-Geneous Ldl Cholesterol Reagent, N-Geneous Ldl Cholesterol Calibrator, Genzyme Ldl Cholesterol Control SetK971573 · Genzyme Corp. · Jun 18, 1997
| Started | Recall | Status |
|---|---|---|
| Feb 10, 2003 | Z-1099-04Expiration date on the reagent cartridges and kit box were incorrect in that they were about 6 months beyond the actual expiration date. | Terminated |
- Atellica® CH HDL Cholesterol (HDLC)& Atellica® CH LDL Cholesterol (LDLC)K241800 · Siemens Healthcare Diagnostics, Inc. · Jul 26, 2024
- AXINON® LDL-p Test SystemK210801 · Numares AG · Jul 19, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 13, 2001
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1475
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files